• CLINICAL QUESTION
    • Do statins reduce rates of cardiovascular events when used for primary prevention?
  • BOTTOM LINE
    • When used for primary prevention, statins are associated with lower rates of all-cause mortality, major vascular events, and revascularizations compared with placebo. Statin therapy is not associated with increased rates of life-threatening adverse effects such as cancer.